CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype

Published:2017-01 Issue: Volume:385 Page:46-50
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Luo Guopei,Liu Chen,Guo Meng,Long Jiang,Liu Zuqiang,Xiao Zhiwen,Jin Kaizhou,Cheng He,Lu Yu,Ni Quanxing,Yu Xianjun

Funder

National Science Foundation for Distinguished Young Scholars of China

National Natural Science Foundation of China

Prospective Clinical Trial Project, Shanghai Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Pancreatic adenocarcinoma;Ryan;N. Engl. J. Med.,2014

2. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

3. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China;Long;Cancer Lett.,2014

4. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure;Ferrone;Surgery,2012

5. Whole genomes redefine the mutational landscape of pancreatic cancer;Waddell;Nature,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Levels in Patients with Pancreatic Cancer;Annals of Surgical Oncology;2023-05-29

2. Outcomes of Modified FOLFIRINOX Regimen on Immune Function and Serum Tumor Markers in the Therapy of Advanced Pancreatic Cancer;J BIOL REG HOMEOS AG;2023

3. Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center;Frontiers in Oncology;2022-07-29

4. A clinical study of serum human epididymis protein 4 (HE4) in the diagnosis of pancreatic cancer;Indian Journal of Cancer;2022-04

5. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3